Definium Therapeutics earnings
When DFTX reports, and what its stock did after each report.
Next report
Expected around early February, going by its own filing history. The company has not announced a date yet. Its matching report came Feb 26, 2026, after the close.
Who else reports that week: the earnings calendar.
Last report: Nov 9, 2026, 16:10 ET (after the close). The filing on SEC EDGAR ↗
After each report
SEC EDGAR · 1D EODMoves are only shown for reports where we hold closing prices.
- Nov 9, 202616:10 ET · after the close8-K ↗no price dataEPS −$0.46quarter to Sep 30, 2026
- Aug 6, 202616:10 ET · after the close8-K ↗no price dataEPS −$1.44quarter to Jun 30, 2026
- May 7, 202616:12 ET · after the close8-K ↗no price dataEPS −$0.71quarter to Mar 31, 2026
- Feb 26, 202616:10 ET · after the close8-K ↗no price data
- Jan 12, 202608:24 ET · before the open8-K ↗no price data
- Nov 6, 202516:12 ET · after the close8-K ↗no price dataEPS −$0.78quarter to Sep 30, 2025
- Jul 31, 202516:10 ET · after the close8-K ↗no price dataEPS −$0.50quarter to Jun 30, 2025
- May 8, 202507:15 ET · before the open8-K ↗no price dataEPS −$0.35quarter to Mar 31, 2025
- Mar 6, 202507:30 ET · before the open8-K ↗no price data
- Nov 7, 202416:15 ET · after the close8-K ↗no price dataEPS −$0.27quarter to Sep 30, 2024
- Aug 12, 202408:38 ET · before the open8-K ↗no price dataEPS −$0.26quarter to Jun 30, 2024
- May 8, 202416:10 ET · after the close8-K ↗no price dataEPS −$1.14quarter to Mar 31, 2024
- Feb 28, 202407:15 ET · before the open8-K ↗no price data
- Nov 2, 202316:15 ET · after the close8-K ↗no price dataEPS −$0.45quarter to Sep 30, 2023
Move = the first close after the release against the close before it. A release after 4pm ET is priced by the next session; one before 9:30am ET by that day’s. Times are when the SEC accepted the 8-K (Item 2.02), which follows the press release by minutes. 2 other Item 2.02 filings, filed weeks ahead of a report (a delivery or preliminary update), are not counted as reports. Prior-session closes only; not a forecast, not advice.